KCM
NVO

Karp Capital Management’s Novo Nordisk NVO Stock Holding History

Karp Capital Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-1,882
Closed -$43K – 287
2018
Q4 		$43K Buy
+1,882
New +$41.8K 0.02% 151
2015
Q4 		– Sell
-850
Closed -$23K – 224
2015
Q3 		$23K Hold
850
– – 0.02% 220
2015
Q2 		$23K Buy
+850
New +$23.9K 0.02% 236

Other funds holding NVO

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Karp Capital Management's NVO Position: Q1 2019 in Review

Karp Capital Management sold out of Novo Nordisk (NVO) in Q1 2019, closing a stake of 1,882 shares — an estimated $43K sold.

Karp Capital Management first reported a position in NVO in Q2 2015 and held it in 3 quarters. The position peaked at $43K in Q4 2018. 580 funds tracked by Wall St. Rank hold NVO as of Q1 2019.

  • Karp Capital Management reported no remaining Novo Nordisk position as of Q1 2019 after selling out during the quarter.
  • Karp Capital Management sold 1,882 Novo Nordisk shares in Q1 2019, an estimated $43K.
  • Karp Capital Management first reported a position in Novo Nordisk in Q2 2015 and held it in 3 quarters.
  • Karp Capital Management's Novo Nordisk position peaked at $43K in Q4 2018.
  • 580 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2019.

Based on Karp Capital Management's 13F filing for Q1 2019, filed 7 May 2019.